Literature DB >> 12953144

Mycobacteria induces pleural mesothelial permeability by down-regulating beta-catenin expression.

K A Mohammed1, N Nasreen, J Hardwick, R D Van Horn, K L Sanders, V B Antony.   

Abstract

Patients with pulmonary tuberculosis develop pleural effusions with a high protein content. Pleural mesothelial adherens junctions promote mesothelial cell-cell adhesion and contribute to pleural integrity. In the present study we have investigated the effect of mycobacterium (BCG) on mesothelial cell adherens junction proteins and pleural permeability. BCG enhanced pleural mesothelial cell (PMC) release of vascular endothelial growth factor (VEGF), and decreased electrical resistance across the PMC monolayer. Neutralizing antibodies to VEGF significantly restored the drop in PMC electrical resistance caused by BCG. BCG infection down regulated beta-catenin (adherens junction protein) expression and caused increased permeability across confluent mesothelial monolayer. Our results suggest that in TB pleurisy, mycobacteria cause VEGF release from mesothelial cells and leads to protein exudation by altering mesothelial adherens junction proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12953144     DOI: 10.1007/s00408-003-1006-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  20 in total

Review 1.  Cadherins: a molecular family important in selective cell-cell adhesion.

Authors:  M Takeichi
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

Review 2.  Pleural empyema.

Authors:  R E Bryant; C J Salmon
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

Review 3.  The biology of vascular endothelial growth factor.

Authors:  N Ferrara; T Davis-Smyth
Journal:  Endocr Rev       Date:  1997-02       Impact factor: 19.871

4.  Bacterial induction of pleural mesothelial monolayer barrier dysfunction.

Authors:  K A Mohammed; N Nasreen; J Hardwick; C S Logie; C E Patterson; V B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

Review 5.  Morphogenetic roles of classic cadherins.

Authors:  M Takeichi
Journal:  Curr Opin Cell Biol       Date:  1995-10       Impact factor: 8.382

6.  Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.

Authors:  H Roh; D W Green; C B Boswell; J A Pippin; J A Drebin
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

7.  Identification of proteins in a human pleural exudate using two-dimensional preparative liquid-phase electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  C L Nilsson; M Puchades; A Westman; K Blennow; P Davidsson
Journal:  Electrophoresis       Date:  1999 Apr-May       Impact factor: 3.535

8.  Effect of local anti-VEGF antibody treatment on tumor microvessel permeability.

Authors:  H C Lichtenbeld; N Ferarra; R K Jain; L L Munn
Journal:  Microvasc Res       Date:  1999-05       Impact factor: 3.514

9.  Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces.

Authors:  A B Moy; J Van Engelenhoven; J Bodmer; J Kamath; C Keese; I Giaever; S Shasby; D M Shasby
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

10.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.

Authors:  W G Roberts; G E Palade
Journal:  J Cell Sci       Date:  1995-06       Impact factor: 5.285

View more
  8 in total

1.  Potential role of AQP1 and VEGF in the development of malignant pleural effusion in mice.

Authors:  Jing Xuan Zhang; C M Xie; Z W Zhu; H Y Huang; Z L Zeng
Journal:  Med Oncol       Date:  2011-04-26       Impact factor: 3.064

2.  Mechanisms of T-lymphocyte accumulation during experimental pleural infection induced by Mycobacterium bovis BCG.

Authors:  Mariana C Souza; Carmen Penido; Maria F S Costa; Maria Graças Henriques
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

3.  Silencing receptor EphA2 induces apoptosis and attenuates tumor growth in malignant mesothelioma.

Authors:  Kamal A Mohammed; Xiaohong Wang; Eugene P Goldberg; Veena B Antony; Najmunnisa Nasreen
Journal:  Am J Cancer Res       Date:  2011-02-10       Impact factor: 6.166

Review 4.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

5.  Arginine-conjugated albumin microspheres inhibits proliferation and migration in lung cancer cells.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Eugene P Goldberg; Najmunnisa Nasreen
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

6.  Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro.

Authors:  Najmunnisa Nasreen; Kamal A Mohammed; Kamal K Mubarak; Maher A Baz; Olufemi A Akindipe; Sebastian Fernandez-Bussy; Veena B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-01       Impact factor: 5.464

7.  New-onset malignant pleural effusion after abscess formation of a subcarinal lymph node associated with endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Sun Mi Jang; Min Ji Kim; Jeong Su Cho; Geewon Lee; Ahrong Kim; Jeong Mi Kim; Chul Hong Park; Jong Man Park; Byeong Gu Song; Jung Seop Eom
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-10-31

8.  Genome-wide association study identifies two risk loci for tuberculosis in Han Chinese.

Authors:  Ruijuan Zheng; Zhiqiang Li; Fusheng He; Haipeng Liu; Jianhua Chen; Jiayu Chen; Xuefeng Xie; Juan Zhou; Hao Chen; Xiangyang Wu; Juehui Wu; Boyu Chen; Yahui Liu; Haiyan Cui; Lin Fan; Wei Sha; Yin Liu; Jiqiang Wang; Xiaochen Huang; Linfeng Zhang; Feifan Xu; Jie Wang; Yonghong Feng; Lianhua Qin; Hua Yang; Zhonghua Liu; Zhenglin Cui; Feng Liu; Xinchun Chen; Shaorong Gao; Silong Sun; Yongyong Shi; Baoxue Ge
Journal:  Nat Commun       Date:  2018-10-04       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.